APAC will Grow the Fastest in the Real-World Evidence Solutions Market The real-world evidence solutions market will power at a double-digit rate by the end of this decade, to touch USD 3,974 million by 2030, as stated by P&S Intelligence. This is because of the clinical trial count, the shifting emphasis to value-based healthcare from volume-based, and the increasing research and development activities associated with the expansion of medical devices and drugs. More than a few biopharma, drug, and medical device organizations are profoundly investing in research and development for the formation of novel gadgets and drugs. These corporations are choosing entirely functional or combined outsourcing services, from the initial to the later-stage developmental phase, for encountering the requirements for both drug development and discovery. Read More: https://www.psmarketresearch.com/market-analysis/real-world-evidence-solutions-market